Stonepine Capital Management, LLC Synlogic, Inc. Transaction History

Stonepine Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.89 - $2.47 $864,536 - $2.4 Million	-971,389 Reduced 91.28%	92,746 $107,000
Q4 2021 Feb 14, 2022	BUY	$2.27 - $3.0 $145,586 - $192,405	64,135 Added 6.41%	1,064,135 $2.58 Million
Q3 2021 Nov 12, 2021	BUY	$2.45 - $4.1 $2.45 Million - $4.1 Million	1,000,000 New	1,000,000 $3.05 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $105M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.